Article Correctness Is Author's Responsibility: Pimavanserin Reduced Symptoms of Dementia-Related Psychosis in Phase 3 Trial July 29, 2020 Author: Neuroscience News Category: Alzehimer's diseaseThe article below may contain offensive and/or incorrect content. Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.